Company Information

IOL CHEMICALS AND PHARMACEUTICALS LTD.

NSE : IOLCPBSE : 524164ISIN CODE : INE485C01011Industry : Pharmaceuticals & DrugsHouse : Trident
BSE399.250.2 (+0.05 %)
PREV CLOSE ( ) 399.05
OPEN PRICE ( ) 398.25
BID PRICE (QTY) 398.65 (2)
OFFER PRICE (QTY) 399.35 (54)
VOLUME 19017
TODAY'S LOW / HIGH ( )394.00 405.05
52 WK LOW / HIGH ( )350.3 535.6
NSE398.65-1.7 (-0.42 %)
PREV CLOSE( ) 400.35
OPEN PRICE ( ) 402.90
BID PRICE (QTY) 398.65 (24)
OFFER PRICE (QTY) 399.05 (54)
VOLUME 136966
TODAY'S LOW / HIGH( ) 394.10 405.00
52 WK LOW / HIGH ( )350.55 535.9
ChairmanRajender Mohan Malla
Managing DirectorVarinder Gupta
Company SecretaryAbhay Raj Singh
Executive DirectorAbhiraj Gupta
Kushal Kumar Rana
Joint Managing DirectorVikas Gupta
Non Executive Independent DirectorSandhya Mehta
Harpal Singh
Sharad Tyagi
Incorporation Year : 1986

Registered Office :

Address : Village Fatehgarh Channa,Mansa Road, Barnala,
Punjab-148101 .

Phone : 01679-285285-86

Email :  investor@iolcp.com 

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE,MCX

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.